Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Blast Pharma Ltd (NASDAQ:ORPN)

3.03
Delayed Data
As of Feb 05
 +0.02 / +0.66%
Today’s Change
2.58
Today|||52-Week Range
8.50
-21.71%
Year-to-Date
No recent news for Bio Blast Pharma Ltd.

Today’s Trading

Previous close3.01
Today’s open3.08
Day’s range2.95 - 3.14
Volume5,995
Average volume (3 months)33,030
Market cap$43.1M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-307.14%
Earnings growth (this year)-71.93%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc-0.06-5.04%
QUREUniqure NV-1.08-6.52%
VBIVVBI Vaccines Inc-0.16-7.55%
STEMStemCells Inc-0.01-2.08%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 16, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$0.00
Annual profit (last year)-$7.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Colin J. Foster
Chief Financial Officer
Robert W. Cook
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers